PHARMACEUTICALS : FALSIFIED MEDICINES: PARLIAMENT WRAPS UP PACKAGE.

The second component of the pharmaceuticals package, which deals with falsified medicines, has officially completed its passage through the European Parliament: MEPs validated at first reading the agreement on the draft directive negotiated with the Council in late December 2010. The directive, which tightens the surveillance of medicines in legal trading channels, is slated to enter into force in late 2012 or early 2013, although certain technical provisions might take longer to implement. A period of up to five or six years is allowed for the required technical adaptations, such as the establishment of a common safety feature to allow checks of the authenticity of a medicine, to identify individual packages and to detect traces of tampering.

Currently there are a number of distinctive signs to certify the authenticity of a medicine, but these vary from one member state to the next. With this directive, a single identifier will be affixed to all prescription medicines in the European Union, unless they have been proven to be risk-free through a risk assessment. For non-prescription drugs, the principle is reversed: they will not be covered by the system unless they represent a risk to health.

Generally speaking, the directive introduces stricter standards for the entire supply chain, both for wholesale distributors of medicines and for brokers involved in their purchase and sale. Wholesalers, for example, will be subject to stricter record-keeping requirements, while brokers may have to undergo repeated inspections.

These standards are not limited to European Union territory: the manufacture of active substances, for instance, will be subject to a code of best manufacturing practice whether the ingredients are manufactured in the Union or imported (which is often the case). The manufacture and distribution of European medicines for export to third countries will have to...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT